| 1978: |
 |
Improvement of regularity and microflora in elderly |
| 1979: |
Acute and chronic toxicity test of BB536 |
| 1981: |
Administration to leukemia patients |
| 1987: |
Prevention of diarrhea by erythromycin |
| 1988: |
Administration to leukemia patients (effects on Candida infection) |
| 1991: |
Immuno stimulation and anti-infection of BB536 |
| 1993: |
Suppression of quinoline (IQ) induced cancer by BB536 |
| 1994: |
Administration to premature infants & development of bifidus flora |
| 1994: |
Suppression of azoxymethane (AOM) induced aberrant crypt foci (ACF) by BB536 |
| 1997: |
Suppression of azoxymethane (AOM) induced cancer biomarkers by BB536 |
| 1997: |
Improvement of microflora balance and regularity by BB536 milk |
| 1997: |
Improvement of microflora balance and regularity by BB536 yogurt |
| 1999: |
Improvement of intestinal environment by BB536 yogurt |
| 2003: |
Anti-lethal activity to the O157 infection |
| Many of the studies listed above can be found in scientific journals. |
